Singapore Inhalation & Nasal Spray Generic Drugs Market Size & Outlook
The inhalation & nasal spray generic drugs market in Singapore is expected to reach a projected revenue of US$ 237.2 million by 2030. A compound annual growth rate of 7.4% is expected of Singapore inhalation & nasal spray generic drugs market from 2024 to 2030.
Revenue, 2023 (US$M)
$144.2
Forecast, 2030 (US$M)
$237.2
CAGR, 2024 - 2030
7.4%
Report Coverage
Singapore
Singapore inhalation & nasal spray generic drugs market, 2018-2030 (US$M)
Related Markets
Singapore inhalation & nasal spray generic drugs market highlights
- The Singapore inhalation & nasal spray generic drugs market generated a revenue of USD 144.2 million in 2023 and is expected to reach USD 237.2 million by 2030.
- The Singapore market is expected to grow at a CAGR of 7.4% from 2024 to 2030.
- In terms of segment, bronchodilators was the largest revenue generating drug class in 2023.
- Combination Drugs is the most lucrative drug class segment registering the fastest growth during the forecast period.
Inhalation & nasal spray generic drugs market data book summary
| Market revenue in 2023 | USD 144.2 million |
| Market revenue in 2030 | USD 237.2 million |
| Growth rate | 7.4% (CAGR from 2023 to 2030) |
| Largest segment | Bronchodilators |
| Fastest growing segment | Combination Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bronchodilators, Combination Drugs, Corticosteroids, Decongestant Sprays, Antihistamines, Other Drug Classes |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Novartis AG ADR, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries, Beximco Pharmaceuticals Ltd DR, Mylan, Akorn, Apotex Inc., Nephron Pharmaceuticals |
Other key industry trends
- In terms of revenue, Singapore accounted for 0.7% of the global inhalation & nasal spray generic drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China inhalation & nasal spray generic drugs market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,947.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inhalation & Nasal Spray Generic Drugs Market Scope
Inhalation & nasal spray generic drugs market segmentation & scope
Bronchodilators
Combination Drugs
Corticosteroids
Decongestant Sprays
Antihistamines
Other Drug Classes
Inhalation & Nasal Spray Generic Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore inhalation & nasal spray generic drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhalation & nasal spray generic drugs market will help companies and investors design strategic landscapes.
Bronchodilators was the largest segment with a revenue share of 30.03% in 2023. Horizon Databook has segmented the Singapore inhalation & nasal spray generic drugs market based on bronchodilators, combination drugs, corticosteroids, decongestant sprays, antihistamines, other drug classes covering the revenue growth of each sub-segment from 2018 to 2030.
- Singapore Inhalation & Nasal Spray Generic Drugs Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Bronchodilators
- Combination Drugs
- Corticosteroids
- Decongestant Sprays
- Antihistamines
- Other Drug Classes
- Singapore Inhalation & Nasal Spray Generic Drugs Indication Outlook (Revenue, USD Million, 2018-2030)
- Asthma
- Chronic Obstructive Pulmonary Disease
- Allergic Rhinitis
- Others Indications
- Singapore Inhalation & Nasal Spray Generic Drugs Patient Demographics Outlook (Revenue, USD Million, 2018-2030)
- Adult Patient
- Pediatric Patient
- Geriatric Patient
- Singapore Inhalation & Nasal Spray Generic Drugs End Use Outlook (Revenue, USD Million, 2018-2030)
- Homecare
- Hospitals
- Other End-users
- Singapore Inhalation & Nasal Spray Generic Drugs Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Retail Pharmacies
- Hospitals Pharmacies
- Online Pharmacies
Reasons to subscribe to Singapore inhalation & nasal spray generic drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Singapore inhalation & nasal spray generic drugs market databook
-
Our clientele includes a mix of inhalation & nasal spray generic drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore inhalation & nasal spray generic drugs market , including forecasts for subscribers. This country databook contains high-level insights into Singapore inhalation & nasal spray generic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Singapore inhalation & nasal spray generic drugs market size, by drug class, 2018-2030 (US$M)
Singapore Inhalation & Nasal Spray Generic Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
